7 minute read

Proposed Slate of 2023–2025 AAN Board of Directors

Center (1981–1985) and a research fellowship in cerebrovascular disease at Duke University (1985–1987).

Goldstein advanced at Duke to the rank of professor of neurology and director of the Duke Stroke Center until moving to the University of Kentucky in 2015.

Goldstein’s clinical and scholarly work focuses on stroke and related disorders. He has published over 820 peer review journal articles, reviews, editorials, book chapters, abstracts, and other professional papers. His research spans strokerelated laboratory-based studies, clinical trials, quality of care and care delivery studies, as well as clinical effectiveness and epidemiological investigations. He serves as a reviewer for multiple professional journals as well as national and international granting agencies. He is a member of the editorial boards of Stroke, Cerebrovascular Diseases, the Journal of Stroke and Cerebrovascular Diseases, and Cardiology Today. He has chaired or been a member of several national guideline writing committees.

Goldstein has been a member of the AAN Quality Standards Subcommittee (2005–2007), the Practice Committee (2007–2015), the Stroke Systems Work Group (2007–2017), the Education Committee (2017–current), the Joint Audit Committee (2017–2012; vice chair 2019–2021), Neurology Chair’s Work Group/Subcommittee (2018–current), Health Policy Subcommittee (2019–current), and is an AAN Media Expert (2019–current). He has been a member of the Board of Directors of the American Heart Association (2002–2004, 2008–2011), as well as having multiple leadership roles within the organization. He was also appointed to the FDA Peripheral and Central Nervous System Advisory Committee (2005–2009; 2014–2019) and served as advisor or panel member for several other FDA committees in addition to the CMS Medicare Evidence Development & Coverage Advisory Committee (2013–2015), and as a member of the National Committee for Quality Assurance Advisory Committee.

Goldstein received the AAN’s G. Milton Shy Award (1979) and numerous other national and state awards. He was awarded the Order of the Long Leaf Pine, North Carolina’s highest civilian honor, by the governor in 2015 for his service to the state related to improving stroke care.

Lily Jung Henson, MD, MMM, FAAN, is the chief executive officer of the Piedmont Augusta Hub in Augusta, GA. Prior to that she served three years as the CEO of Piedmont Henry Hospital in Stockbridge, GA. She formerly served as the chief medical officer at Piedmont Henry as well as the former chief of neurology of the Piedmont Healthcare System in Atlanta, GA. Prior to her move to Atlanta in 2015, Henson served as the vice president of medical affairs of Swedish Ballard Hospital in Seattle, WA, continued from page 13 after her tenure as the inaugural chief of staff of Swedish Issaquah Hospital.

Henson has been a neurologist with 30 years of practice with a focus on multiple sclerosis and a principal investigator in many clinical trials involving MS disease-modifying therapies. She was an associate professor of neurology at the University of Washington Medical School.

Henson attended the Honors Program in Medical Education at Northwestern University in Chicago, where she obtained her BS and MD degrees. She completed her neurology training at the University of Washington in Seattle. She went on to get a certificate of medical management and a Master of Medical Management through Tulane University’s School of Public Health and Tropical Medicine. She is a 2016 ACHE Thomas Dolan Executive Diversity Scholar. She is a fellow of the American College of Healthcare Executives and a past regent-at-large of District 2.

Henson is the former chair of the board of directors of the Hands of Hope Clinic in Stockbridge, GA. She served on the national board of directors of the National Multiple Sclerosis Society, the board of managers of Fast Forward, and was a board trustee of the Georgia Chapter and the Greater Northwest Chapter of the NMSS. She also served as the chair of BrainPAC of the American Academy of Neurology, the advocacy editor of the AAN’s website, and as vice chair of the AAN Government Relations Committee.

Shannon M. Kilgore, MD, FAAN, serves as the deputy associate chief of staff for education at the Veterans Affairs Health Care System in Palo Alto, CA. In addition to her education role, her clinical focus is in primarily movement disorders, though she also directs stroke care at VA Palo Alto. With a keen interest in medication safety and fairness in pharmaceutical pricing, Kilgore represents neurology on the Medical Advisory Panel to Pharmacy Benefits Management, which determines the formulary for the Department of Veterans Affairs.

Kilgore obtained her Bachelor of Arts in psychology from the University of Texas at Austin, and her Doctor of Medicine from the University of Texas Health Science Center at Houston/McGovern Medical School. She then completed her neurology residency and fellowships in both cerebrovascular disease and movement disorders at Stanford. She brought this unique combination of experience to the VA, where she has taught medical students, neurology residents, and geriatrics fellows in both outpatient and inpatient settings, as a clinical associate professor, affiliated of Stanford’s Department of Neurology. At Stanford, she serves as the site director for the neurology residency program and as a member of the Clinical Competency Committee.

Kilgore has maintained a long-held passion in combining both education and advocacy. She served on the ACGME Review Committee for Neurology twice, both as a resident/ fellow, and again as a full member, vice-chair, and chair. She has continued work within the ACGME on multiple Milestones committees. Having represented the AAN at the American Medical Association (AMA) since 2004, she was elected to the AMA’s Council on Medical Education in 2019, allowing her to advocate for medical students, residents, international medical graduates, and practicing physicians to the various accreditation/ certification/licensure and oversight bodies within medicine. In this capacity, she now represents the AMA to the Accreditation Council for Continuing Medical Education Board of Directors.

Kilgore also serves the Academy on the Editorial Board of Continuum: Lifelong Learning in Neurology ® and the Education Committee, overseeing the Program Accreditation Work Group. She has also been a member of the Government Relations Committee and has served on multiple task forces. A member of the 2014–2015 Emerging Leaders Forum class, she now enjoys giving back to the AAN as a mentor within the various AAN Leadership Programs.

Jeffrey C. McClean II, MD, FAAN, is currently chair of the Department of Medicine at Brooke Army Medical Center (BAMC), the largest, busiest hospital in the Department of Defense health system. Previously, McClean was deputy chair for the BAMC Department of Medicine, and prior to this he served four years as the program director of the only neurology residency in the US Air Force (USAF). He is an associate professor of neurology with the Uniformed Services University of the Health Sciences (USUHS). He is also the neurology chief consultant to the USAF surgeon general, providing guidance for a network of neurology clinics across the country and overseas.

McClean obtained his undergraduate degree from Harvard College in 1999 and his medical degree from USUHS in 2005. After finishing his neurology residency at Wilford Hall Medical Center in 2009, he completed a fellowship in neuromuscular medicine at Harvard (Brigham & Women’s Hospital and Massachusetts General Hospital) in 2010.

His engagement with the AAN began with his participation in the Emerging Leaders Forum in 2013–2014. He has served on the Member Engagement Committee, Digital Strategy Subcommittee, Diversity Leadership Subcommittee, and Nominations Committee. He is a member of the Brain & Life® Editorial Board and was a founding co-editor of Equity, Diversity, and Inclusion for Neurology® He is vice chair of the Leadership Development Committee; chair of the Inclusion, Diversity, Equity, Anti-racism, and Social Justice Subcommittee; and previously served as chair of the AAN Special Commission on Racism, Inequities, and Social Justice. McClean is also a member of the Alpha Omega Alpha Honor Medical Society and an AOA Leadership Fellow.

Bruce Ovbiagele, MD, MSc, MAS, MBA, MLS, FAAN, is professor of neurology and associate dean at the University of California, San Francisco, as well as chief of staff at the San Francisco Veterans Affairs Health Care System. Prior to these roles, he served for six years as professor of neurology and chair of the department of neurology at the Medical University of South Carolina. His primary research involves the translation of evidencebased interventions into clinical practice and community settings to improve stroke outcomes for underserved and vulnerable populations in the United States and around the world. He currently leads several NIH-funded studies of stroke in the US and sub-Saharan Africa. Ovbiagele has published over 600 peer-reviewed articles (h-index 87) in the areas of stroke prevention, epidemiology, risk factors, and outcomes, and has edited five textbooks. His work has been recognized with several awards including the Michael S. Pessin Stroke Leadership Award and Robert Wartenberg Lecture award from the AAN; Penn Award from the American Neurological Association; Mridha Humanitarian Award from the American Brain Foundation; Feinberg Award and Stroke Council Award from the American Stroke Association; Haddock International Impact Award and Distinguished Scientist Award from the American Heart Association; and Meritorious Achievement Award from the National Medical Association.

Ovbiagele has been a member of the AAN since 1998. He has been privileged to serve on several committees and subcommittees including the Clinical Research Training Fellowship Award Committee, Clinical Research Subcommittee, Minority Scholars Subcommittee, and Education Committee. He was a Neurology on the Hill participant in 2008, Palatucci Advocacy Leadership Forum graduate in 2009, and Minority Scholars Visiting Professor to Morehouse School of Medicine in 2011. He has served as director of stroke courses at both the Annual Meeting and Fall Conference, faculty chair/guest editor for a Continuum® issue, and abstracts reviewer for the AAN Annual Meeting. He presently directs the Health Equity for Neurologists course at the Annual Meeting. Ovbiagele is a member of the AAN’s Media Expert Panel.

Ovbiagele chaired the International Stroke Conference (2016–2018), served as an associate editor of Stroke (2020–2022), and is the current editor-in-chief of the Journal of the American Heart Association. He is an elected member of the National Academy of Medicine and Association of American Physicians; as well as an elected fellow of the World Academy of Sciences, World Stroke Organization, American Association for the Advancement of Science, Royal College of Physicians (London), and Royal Society of Public Health.

This article is from: